|
1
|
Dong C, Wilhelm D and Koopman P: Sox genes
and cancer. Cytogenet Genome Res. 105:442–447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: Biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stevanovic M, Zuffardi O, Collignon J,
Lovell-Badge R and Goodfellow P: The cDNA sequence and chromosomal
location of the human SOX2 gene. Mamm Genome. 5:640–642. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weina K and Utikal J: SOX2 and cancer:
Current research and its implications in the clinic. Clin Transl
Med. 3:192014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomson JA, Itskovitz-Eldor J, Shapiro SS,
Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM: Embryonic stem
cell lines derived from human blastocysts. Science. 282:1145–1147.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masui S, Nakatake Y, Toyooka Y, Shimosato
D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, et
al: Pluripotency governed by Sox2 via regulation of Oct3/4
expression in mouse embryonic stem cells. Nat Cell Biol. 9:625–635.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang S and Cui W: Sox2, a key factor in
the regulation of pluripotency and neural differentiation. World J
Stem Cells. 6:305–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu T, Cheng W, Huang Y, Huang Q, Jiang L
and Guo L: Human amniotic epithelial cell feeder layers maintain
human iPS cell pluripotency via inhibited endogenous microRNA-145
and increased Sox2 expression. Exp Cell Res. 318:424–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chew JL, Loh YH, Zhang W, Chen X, Tam WL,
Yeap LS, Li P, Ang YS, Lim B, Robson P, et al: Reciprocal
transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2
complex in embryonic stem cells. Mol Cell Biol. 25:6031–6046. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Avilion AA, Nicolis SK, Pevny LH, Perez L,
Vivian N and Lovell-Badge R: Multipotent cell lineages in early
mouse development depend on SOX2 function. Genes Dev. 17:126–140.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizuseki K, Kishi M, Matsui M, Nakanishi S
and Sasai Y: Xenopus Zic-related-1 and Sox-2, two factors induced
by chordin, have distinct activities in the initiation of neural
induction. Development. 125:579–587. 1998.PubMed/NCBI
|
|
13
|
Archer TC, Jin J and Casey ES: Interaction
of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis. Dev Biol.
350:429–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Basu-Roy U, Seo E, Ramanathapuram L, Rapp
TB, Perry JA, Orkin SH, Mansukhani A and Basilico C: Sox2 maintains
self renewal of tumor-initiating cells in osteosarcomas. Oncogene.
31:2270–2282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rybak AP and Tang D: SOX2 plays a critical
role in EGFR-mediated self-renewal of human prostate cancer
stem-like cells. Cell Signal. 25:2734–2742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boumahdi S, Driessens G, Lapouge G, Rorive
S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E,
et al: SOX2 controls tumour initiation and cancer stem-cell
functions in squamous-cell carcinoma. Nature. 511:246–250. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L,
Liu Y, Reisfeld RA, Xiang R, Lv D, et al: SOX2 gene regulates the
transcriptional network of oncogenes and affects tumorigenesis of
human lung cancer cells. PLoS One. 7:e363262012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang YH, Luo MH, Ni YB, Tsang JY, Chan
SK, Lui PC, Yu AM, Tan PH and Tse GM: Increased SOX2 expression in
less differentiated breast carcinomas and their lymph node
metastases. Histopathology. 64:494–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Girouard SD, Laga AC, Mihm MC, Scolyer RA,
Thompson JF, Zhan Q, Widlund HR, Lee CW and Murphy GF: SOX2
contributes to melanoma cell invasion. Lab Invest. 92:362–370.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014.PubMed/NCBI
|
|
21
|
Sun C, Sun L, Li Y, Kang X, Zhang S and
Liu Y: Sox2 expression predicts poor survival of hepatocellular
carcinoma patients and it promotes liver cancer cell invasion by
activating Slug. Med Oncol. 30:5032013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lou XI, Han X, Jin C, Tian W, Yu W, Ding
D, Cheng L, Huang B, Jiang H and Lin B: SOX2 targets fibronectin 1
to promote cell migration and invasion in ovarian cancer: New
molecular leads for therapeutic intervention. OMICS. 17:510–518.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiang R, Liao D, Cheng T, Zhou H, Shi Q,
Chuang TS, Markowitz D, Reisfeld RA and Luo Y: Downregulation of
transcription factor SOX2 in cancer stem cells suppresses growth
and metastasis of lung cancer. Br J Cancer. 104:1410–1417. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Chang DY, Mercado-Uribe I and Liu
J: Sex-determining region Y-box 2 expression predicts poor
prognosis in human ovarian carcinoma. Hum Pathol. 43:1405–1412.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu KR, Yang SR, Jung JW, Kim H, Ko K, Han
DW, Park SB, Choi SW, Kang SK, Schöler H, et al: CD49f enhances
multipotency and maintains stemness through the direct regulation
of OCT4 and SOX2. Stem Cells. 30:876–887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morgan TM, Koreckij TD and Corey E:
Targeted therapy for advanced prostate cancer: Inhibition of the
PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets. 9:237–249. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li D, Zhao LN, Zheng XL, Lin P, Lin F, Li
Y, Zou HF, Cui RJ, Chen H and Yu XG: Sox2 is involved in paclitaxel
resistance of the prostate cancer cell line PC-3 via the PI3K/Akt
pathway. Mol Med Rep. 10:3169–3176. 2014.PubMed/NCBI
|
|
28
|
Wen W, Han T, Chen C, Huang L, Sun W, Wang
X, Chen SZ, Xiang DM, Tang L, Cao D, et al: Cyclin G1 expands liver
tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Mol Cancer Ther. 12:1796–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Corominas-Faja B, Cufí S,
Oliveras-Ferraros C, Cuyàs E, López-Bonet E, Lupu R, Alarcón T,
Vellon L, Iglesias JM, Leis O, et al: Nuclear reprogramming of
luminal-like breast cancer cells generates Sox2-overexpressing
cancer stem-like cellular states harboring transcriptional
activation of the mTOR pathway. Cell Cycle. 12:3109–3124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gen Y, Yasui K, Nishikawa T and Yoshikawa
T: SOX2 promotes tumor growth of esophageal squamous cell carcinoma
through the AKT/mammalian target of rapamycin complex 1 signaling
pathway. Cancer Sci. 104:810–816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al-Dhfyan A: Embryonic signature in breast
cancers; Pluripotency roots of cancer stem cells. Saudi
pharmaceutical journal : Saudi Pharm J. 21:229–232. 2013.
View Article : Google Scholar
|
|
32
|
Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T,
Liu Y, Li X, Xiang R and Li N: SOX2 promotes tumor metastasis by
stimulating epithelial-to-mesenchymal transition via regulation of
WNT/β-catenin signal network. Cancer Lett. 336:379–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Berezovsky AD, Poisson LM, Cherba D, Webb
CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM,
Mikkelsen T and Carvalho AC: Sox2 promotes malignancy in
glioblastoma by regulating plasticity and astrocytic
differentiation. Neoplasia. 16(193–206): 206e19–25. 2014.
|
|
34
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
Overexpression of SOX2 promotes migration, invasion, and
epithelial-mesenchymal transition through the Wnt/β-catenin pathway
in laryngeal cancer Hep-2 cells. Tumour Biol. 35:7965–7973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jeon SJ, Fujioka M, Kim SC and Edge AS:
Notch signaling alters sensory or neuronal cell fate specification
of inner ear stem cells. J Neurosci. 31:8351–8358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Neves J, Abelló G, Petrovic J and Giraldez
F: Patterning and cell fate in the inner ear: A case for Notch in
the chicken embryo. Dev Growth Differ. 55:96–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan W, Jin Y, Chen J, Rottier RJ, Steel KP
and Kiernan AE: Ectopic expression of activated notch or SOX2
reveals similar and unique roles in the development of the sensory
cell progenitors in the mammalian inner ear. J Neurosci.
33:16146–16157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang YI, Peng J, Zhang H, Zhu Y, Wan L,
Chen J, Chen X, Lin R, Li H, Mao X, et al: Notch1 signaling is
activated in cells expressing embryonic stem cell proteins in human
primary nasopharyngeal carcinoma. J Otolaryngol Head Neck Surg.
39:157–166. 2010.PubMed/NCBI
|
|
39
|
Xu X, Huang L, Futtner C, Schwab B,
Rampersad RR, Lu Y, Sporn TA, Hogan BL and Onaitis MW: The cell of
origin and subtype of K-Ras-induced lung tumors are modified by
Notch and Sox2. Genes Dev. 28:1929–1939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fang XI, Yu W, Li L, Shao J, Zhao N, Chen
Q, Ye Z, Lin SC, Zheng S and Lin B: ChIP-seq and functional
analysis of the SOX2 gene in colorectal cancers. OMICS. 14:369–384.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fang WTI, Fan CC, Li SM, Jang TH, Lin HP,
Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, et al: Downregulation
of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung
squamous cell carcinoma. Int J Cancer. 135:809–819. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Y, Eades G, Yao Y, Li Q and Zhou Q:
Estrogen receptor α signaling regulates breast tumor-initiating
cells by down-regulating miR-140 which targets the transcription
factor SOX2. J Biol Chem. 287:41514–41522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen S, Li X, Lu D, Xu Y, Mou W, Wang L,
Chen Y, Liu Y, Li X, Li LY, et al: SOX2 regulates apoptosis through
MAP4K4-survivin signaling pathway in human lung cancer cells.
Carcinogenesis. 35:613–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
